ERBB2 Amplification as a Predictive and Prognostic Biomarker in Upper Tract Urothelial Carcinoma

SIMPLE SUMMARY: Upper tract urothelial carcinomas (UTUCs) occur in about 5–10% of all urothelial carcinomas and are frequently discovered in high-stage disease. We aimed to evaluate human epidermal growth factor receptor 2 (ERBB2) protein expression and ERBB2 amplification in UTUCs according to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimpfer, Annette, Kdimati, Said, Mosig, Melanie, Rudolf, Henrik, Zettl, Heike, Erbersdobler, Andreas, Hakenberg, Oliver W., Maruschke, Matthias, Schneider, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177383/
https://www.ncbi.nlm.nih.gov/pubmed/37173881
http://dx.doi.org/10.3390/cancers15092414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177383/
https://www.ncbi.nlm.nih.gov/pubmed/37173881
http://dx.doi.org/10.3390/cancers15092414

Ejemplares similares